SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-288325
Filing Date
2017-09-19
Accepted
2017-09-19 16:04:33
Documents
5
Period of Report
2017-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d453139d8k.htm 8-K 23160
2 EX-1.1 d453139dex11.htm EX-1.1 157936
3 EX-5.1 d453139dex51.htm EX-5.1 12714
4 GRAPHIC g453139g0919025238432.jpg GRAPHIC 1785
5 GRAPHIC g453139img001.jpg GRAPHIC 5975
  Complete submission text file 0001193125-17-288325.txt   205806
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 171092051
SIC: 3841 Surgical & Medical Instruments & Apparatus